- About
- Strategic Plan
- Structure
- Governance
- Scientific divisions
- ACRF Chemical Biology
- ACRF Stem Cells and Cancer
- Bioinformatics
- Cancer and Haematology
- Cell Signalling and Cell Death
- Development and Cancer
- Immunology
- Infection and Immunity
- Inflammation
- Molecular Genetics of Cancer
- Molecular Immunology
- Molecular Medicine
- Population Health and Immunity
- Structural Biology
- Systems Biology and Personalised Medicine
- Laboratory operations
- Funding
- Annual reports
- Human research ethics
- Scientific integrity
- Institute life
- Career opportunities
- Business Development
- Partnering opportunities
- Opportunities in platform technologies
- A complete cure for HBV
- A stable efficacious Toxoplasma vaccine
- Activating SMCHD1 to treat FSHD
- Fut8 Sugar coating immuno oncology
- Intercepting inflammation with RIPK2 inhibitors
- Novel checkpoints NK cells emerge as key players in IO
- Precision epigenetics silencing SMCHD1 to treat Prader Willi Syndrome
- Rethinking CD52 a therapy for autoimmune disease
- Targeting plasmacytoid dendritic cells for systemic lupus erythematosus
- Treating Epstein-Barr virus associated malignancies
- Royalties distribution
- Start-up companies
- Partnering opportunities
- Collaborators
- Publications repository
- Awards
- Discoveries
- Centenary 2015
- History
- Contact us
- Research
- Diseases
- Research fields
- Bioinformatics
- Cancer biology
- Cell death
- Cell signalling
- Clinical translation
- Computational biology
- Drug discovery
- Epigenetics
- Flow cytometry
- Genomics
- Haematology
- Imaging
- Immunology
- Infection
- Inflammation
- Medicinal chemistry
- Personalised medicine
- Proteomics
- Stem cells
- Structural biology
- Systems biology
- Vaccine development
- People
- Anne-Laure Puaux
- Associate Professor Aaron Jex
- Associate Professor Alyssa Barry
- Associate Professor Andrew Webb
- Associate Professor Anne Voss
- Associate Professor Chris Tonkin
- Associate Professor Daniel Gray
- Associate Professor Edwin Hawkins
- Associate Professor Grant Dewson
- Associate Professor Isabelle Lucet
- Associate Professor James Murphy
- Associate Professor Jeanne Tie
- Associate Professor Jeff Babon
- Associate Professor Joan Heath
- Associate Professor Justin Boddey
- Associate Professor Marco Herold Marco Herold
- Associate Professor Marnie Blewitt
- Associate Professor Matthew Ritchie
- Associate Professor Mike Lawrence
- Associate Professor Nicholas Huntington
- Associate Professor Oliver Sieber
- Associate Professor Rachel Wong
- Associate Professor Sandra Nicholson
- Associate Professor Seth Masters
- Associate Professor Sumitra Ananda
- Associate Professor Tim Thomas
- Associate Professor Wai-Hong Tham
- Associate Professor Wei Shi
- Catherine Parker
- Dr Anna Coussens
- Dr Ashley Ng
- Dr Ben Tran
- Dr Bob Anderson
- Dr Brad Sleebs
- Dr David Komander
- Dr Diana Hansen
- Dr Drew Berry
- Dr Emma Josefsson
- Dr Ethan Goddard-Borger
- Dr Gary Pitt
- Dr Gwo Yaw Ho
- Dr Hui-Li Wong
- Dr Hélène Jousset Sabroux
- Dr Ian Majewski
- Dr Ian Street
- Dr Jacqui Gulbis
- Dr James Vince
- Dr Jason Tye-Din
- Dr Joanna Groom
- Dr John Wentworth
- Dr Julie Mercer
- Dr Kate Sutherland
- Dr Kelly Rogers
- Dr Ken Pang
- Dr Leanne Robinson
- Dr Leigh Coultas
- Dr Lucy Gately
- Dr Margaret Lee
- Dr Marie-Liesse Asselin-Labat
- Dr Mary Ann Anderson
- Dr Maryam Rashidi
- Dr Matthew Call
- Dr Melissa Call
- Dr Melissa Davis
- Dr Michael Low
- Dr Misty Jenkins
- Dr Peter Czabotar
- Dr Philippe Bouillet
- Dr Priscilla Auyeung
- Dr Rhys Allan
- Dr Ruth Kluck
- Dr Samar Ojaimi
- Dr Samir Taoudi
- Dr Sant-Rayn Pasricha
- Dr Shalin Naik
- Dr Sheau Wen Lok
- Dr Simon Chatfield
- Dr Stephen Wilcox
- Dr Tracy Putoczki
- Guillaume Lessene
- Helene Martin
- Keely Bumsted O'Brien
- Mr Joel Chibert
- Mr Simon Monard
- Mr Stan Balbata
- Mr Steve Droste
- Ms Carolyn MacDonald
- Ms Samantha Ludolf
- Ms Wendy Hertan
- Professor Alan Cowman
- Professor Andreas Strasser
- Professor Andrew Lew
- Professor Andrew Roberts
- Professor Clare Scott
- Professor David Huang
- Professor David Vaux
- Professor Doug Hilton
- Professor Gabrielle Belz
- Professor Geoff Lindeman
- Professor Gordon Smyth
- Professor Ian Wicks
- Professor Ivo Mueller
- Professor Jane Visvader
- Professor Jerry Adams
- Professor John Silke
- Professor Ken Shortman
- Professor Leonard C Harrison
- Professor Li Wu
- Professor Lynn Corcoran
- Professor Marc Pellegrini
- Professor Melanie Bahlo
- Professor Nicos Nicola
- Professor Peter Colman
- Professor Peter Gibbs
- Professor Phil Hodgkin
- Professor Stephen Nutt
- Professor Suzanne Cory
- Professor Terry Speed
- Professor Tony Burgess
- Professor Tony Papenfuss
- Professor Warren Alexander
- Education
- PhD
- Honours
- Masters
- Undergraduate
- Student research projects
- 3D and 4D imaging of thymic T cell differentiation
- Activating https://www.wehi.edu.au/node/add/individual-student-research-page#Parkin to treat Parkinson’s disease
- Activation, regulation, and biological roles of E3 ubiquitin ligases
- Bioinformatics methods for detecting and making sense of somatic genomic rearrangements
- Characterising regulatory T cells in coeliac disease
- Computational melanoma genomics
- Deep profiling of blood cancers during targeted therapy
- Defining the role of necroptosis in platelet production and function
- Determining the migration signals leading to protective immune responses
- Developing mucolytics to treat chronic respiratory diseases
- Developing new tools to visualise necroptotic cell death
- Development of live-cell, automated microscopy techniques for studying malaria
- Development of tools to inform malaria vaccine design
- Discovering new genetic causes of primary antibody deficiencies
- Discovery of novel drug combinations for the treatment of bowel cancer
- Dissecting the induction and integration of T cell migration cues
- Drug targets and compounds that block growth of malaria parasites
- Effects of nutrition on immunity and infection in Asia and Africa
- Eosinophil and neutrophil heterogeneity
- Eosinophil maturation
- Epigenetic regulation of systemic iron homeostasis
- Functional differences between young and old platelets
- Generation of cytokine antagonists
- Genetic dissection of mechanisms of Plasmodium invasion
- Genomic characterisation of epigenetic regulators involved in X inactivation
- High resolution 3-dimensional imaging to characterise metastatic cancers
- High-resolution imaging of host cell invasion by the malaria parasite
- Home renovations: understanding how Toxoplasma redecorates its host cell
- How the epigenetic regulator SMCHD1 works and how to target it to treat disease
- Human monoclonal antibodies against malaria infection
- Identification of malaria parasite entry receptors
- Identification of new therapeutic opportunities for pancreatic cancer
- Identifying disease-causing haplotypes with hidden Markov models
- Interleukin-11 in gastrointestinal bacterial infections
- Investigating mechanisms of cell death and survival using zebrafish
- Investigating new paths to selective modulation of potassium channels
- Let me in! How Toxoplasma invades human cells
- Long-read sequencing for transcriptome and epigenome analysis
- Macro-evolution in cancer
- Mapping DNA repair networks in cancer
- Mapping how multiple malaria episodes are related
- Modelling gene regulatory systems
- Modulation of immune responses by immunosuppressive chemokines
- Molecular basis for inherited Parkinson’s disease mechanism of PINK1
- Mucus at the molecular level
- Novel cell death and inflammatory modulators in lupus
- Plasmodium vivax host-parasite interactions: impact on immunity
- Predicting drug response in cancer
- Programming T cells to defend against infections
- Reconstructing the immune response: from molecules to cells to systems
- Regulation of cytokine signalling
- Screening for regulators of jumping genes
- Target identification of potent antimalarial agents
- Targeting the immune system in cancer
- The role of interleukin-11 in acute myeloid leukaemia
- Transmembrane control of type I cytokine receptor activation
- Uncovering the roles of long non-coding RNAs in human bowel cancer
- Understanding retinal eye diseases with retinal transcriptomic data analysis
- Understanding the role of stromal cells in pancreatic cancer growth
- Unravelling the tumour suppressor network in models of lung cancer
- Utilising pre-clinical models to discover novel therapies for tuberculosis
- Zombieland: evolution of a dead enzyme that kills cells by necroptosis
- School resources
- Frequently asked questions
- Student profiles
- Abebe Fola
- Casey Ah-Cann
- Catia Pierotti
- Charlotte Slade
- Daniel Cameron
- Emma Nolan
- Jason Brouwer
- Joy Liu
- Lucille Rankin
- Rebecca Delconte
- Roberto Bonelli
- Rune Larsen
- Sarah Garner
- Simona Seizova
- Michael Low
- Sofonias Tessema
- Santini Subramaniam
- Miles Horton
- Alexandra Gurzau
- Tamara Marcus
- Nicholas Chandler
- Student achievements
- Student association
- News
- Donate
- Online donation
- Ways to support
- Support outcomes
- Supporter stories
- Rotarians against breast cancer
- A partnership to improve treatments for cancer patients
- 20 years of cancer research support from the Helpman family
- A generous gift from a cancer survivor
- A gift to support excellence in Australian medical research
- An enduring friendship
- Anonymous donor helps bridge the 'valley of death'
- Renewed support for HIV eradication project
- Searching for solutions to muscular dystrophy
- Supporting research into better treatments for colon cancer
- Taking a single cell focus with the DROP-seq
- WEHI.TV
Board

The Institute board governs the Institute, manages policy and provides strategic direction.
Key documents
Mr Christopher W Thomas AM
BCom (Hons) MBA Melbourne FAICD Mr Thomas joined executive search firm Egon Zehnder International in 1979 and was managing partner of the Melbourne office from 1986 to 2003. He was also leader of the firm’s global Board Consulting Practice Group (1998-2006) and chaired the firm’s twice-yearly international partners’ meetings (1997-2007). Mr Thomas is a fellow of the Australian Institute of Company Directors, and is currently a member of the National Gallery of Victoria’s Remuneration and Nomination Committee. He has served on the board of the Corps of Commissionaires (Victoria) and the Council of the Australian Film, Television and Radio School. He was chairman of the Heide Museum of Modern Art, chairman of the Victorian Community Foundation and president of the Melbourne Business School Alumni. |
|
Mrs Jane Hemstritch
BSc (Hons) London University FICAEW FICAA FAICD Mrs Hemstritch was managing director Asia Pacific for Accenture Limited from 2004 until her retirement in February 2007. In this role, Mrs Hemstritch was a member of Accenture’s global executive leadership team and oversaw the management of Accenture’s business portfolio in Asia Pacific. She holds a Bachelor of Science with Honours in biochemistry and physiology and has professional expertise in technology, communications, change management and accounting. Mrs Hemstritch is a member of the Council of The National Library of Australia, the Global Council of Herbert Smith Freehills, the Council of Governing Members of The Smith Family and Chief Executive Women. She is an independent non-executive director of Lend Lease Corporation Limited and Victorian Opera Company Ltd (chairman from February 2013). |
|
Mr Robert Wylie
FCA FAICD Mr Wylie is a fellow of the Australian Institute of Company Directors, a fellow and past president of the Institute of Chartered Accountants in Australia and a member of the Institute of Chartered Accountants in Scotland. He is a non-executive director of Maxitrans Industries Limited. Mr Wylie joined Deloitte in 1973 in the United Kingdom, transferring to Australia in 1976. He was national chairman of Deloitte Australia from 1993 to 2001. He was deputy managing Partner Asia Pacific from 2001 before joining Deloitte & Touche USA as a senior executive partner in 2002 until 2006. He was also a member of The Deloitte Global Board and Global Governance Committee as well as The Deloitte Consulting Global Board. |
|
Mr Malcolm Broomhead AO
BE (Civil), MBA UQ, FIE (Aus), FAusIMM, FAIM, MICE (UK), FAICD Mr Broomhead is a professional non-executive director. His directorships include BHP Billiton Limited and Orica Limited (chairman). Mr Broomhead was formerly managing director and CEO of Orica Limited from 2001 until September 2005. Prior to Orica, he was managing director and CEO of the global diversified resources company North Limited. He has had extensive experience in the resources industry, as well as in finance, investment and construction activities. He has worked in management positions with Halcrow (UK), MIM Holdings, Peko Wallsend and Industrial Equity. |
|
Mr Peter Collins
BA (Hons) Melbourne BTheol MCD MBA Oxford and HEC Paris Peter Collins is the Director of the Centre for Ethical Leadership and Director of the Vincent Fairfax Fellowship. He consults on ethics and leadership with ASX100 companies, Federal and State Government departments and the health and medical research sector. Mr Collins started his consulting career at McKinsey with a focus on organisational change and leadership. Prior to this he worked in Federal Parliament, for the Minister for Foreign Affairs and later the Minister for Health. Mr Collins has been a columnist with The Age, Sydney Morning Herald and Herald Sun, as well as with ABC Radio and Channel 9 reporting on ethical and social issues. Mr Collins has a Master’s degree from the University of Oxford and HEC Paris and is a PhD candidate at the University of Oxford. |
|
Mr John Dyson
BSc Monash Grad Dip Fin Inv SIA MBA RMIT Mr Dyson has been an active participant in the venture capital industry for two decades. He is one of the founders of Starfish Ventures, a venture capital company established in Melbourne in 2001; and former chair of Swinburne Ventures Pty Ltd, the entity responsible for the commercialisation of technology for Swinburne University of Technology. From 1997 to 2002 he was a director of the Australian Venture Capital Association Limited, including deputy chairman in 1998 and chairman in 1999. He is currently a director of technology companies Atmail, Audinate and Myriax. Before moving into venture capital Mr Dyson worked in the investment banking and stockbroking industries for Schroders, Nomura Securities, KPMG and ANZ McCaughan. Mr Dyson is a passionate alpine skier and is a former chairman of the Mount Buller and Mount Stirling Alpine Resort Management Board, which oversees the management of Victoria’s largest alpine resort. He is also a co-trustee of the Dyson Bequest, a $15 million charitable foundation that provides grants to a range of social welfare, education and environmental causes. |
|
Professor Shitij Kapur
MBBS AIIMS PhD Toronto FRCPC FMedSci Professor Shitij Kapur is the dean, Faculty of Medicine, Dentistry and Health Sciences and assistant vice-chancellor (Health), University of Melbourne. Professor Kapur is a clinician-scientist with expertise in psychiatry, neuroscience and brain imaging. He trained as a psychiatrist at the University of Pittsburgh, and undertook a PhD and fellowship at the University of Toronto. He is a diplomate of the American Board of Psychiatry and Neurology, is board certified in Canada and has a specialist medical license in the United Kingdom. He is a Distinguished Fellow of the American Psychiatric Association, Fellow of the Academy of Medical Sciences, UK, and Fellow of King’s College London, UK. He also led NEWMEDS, a European Union-wide innovative medicines initiative and STRATA, a UK-wide program to enhance stratified medicine strategies in psychiatry. |
|
Professor Christine Kilpatrick
MBBS MBA MD DMedSci (Hons) FRACP FRACMA FAICD FAHMS Professor Kilpatrick commenced as chief executive of Melbourne Health in May 2017. She was previously chief executive, The Royal Children’s Hospital (2008-17) and executive director Royal Melbourne Hospital, Melbourne Health (2005-08). Professor Kilpatrick trained as a neurologist, specialising in epilepsy. Professor Kilpatrick has held several external appointments including chair of Victorian Quality Council in Healthcare and member of the Women’s and Children’s Health Board. She was a former board member of Murdoch Children's Research Institute and Royal Children's Hospital Foundation. She was awarded a Centenary Medal in 2003, was included in the 2014 Victorian Honour Roll of Women and received the Distinguished Fellow Award of the RACMA in 2017. |
|
Professor Jim McCluskey
BMedSc MB BS MD UWA FRACP FRCPA FAA FAHMS Professor James McCluskey is deputy vice-chancellor (research) at The University of Melbourne and a Redmond Barry Distinguished Professor in Microbiology and Immunology. He has published widely on the genetic control of specific immunity and his research has been recognised by a number of awards including as joint winner of an Australian Museum Eureka Prize for Scientific Research, the GSK Research Excellence Award and the Victoria Prize for Life Sciences. Professor McCluskey is director of Australian Friends of Asha Slums, the Victorian Comprehensive Cancer Centre and UoM Commercial, the Chair of Nossal Institute Ltd and a past member of the board of directors of the Bionics Institute, the Florey Institute of Neuroscience and Mental Health, the Burnet Institute and St Vincent’s Institute. He established the South Australian node of the Australian Bone Marrow Donor Registry and has consulted for the Australian Red Cross in the area of transplantation matching for more than 25 years. Professor McCluskey led the development of the Peter Doherty Institute for Infection and Immunity, and also led the multiinstitutional team that developed the Atlantic Fellows Social Equity Program supported by The Atlantic Philanthropies. |
|
Ms Marie McDonald
BSc (Hons) LLB (Hons) Melbourne Ms McDonald was a partner of Blake Dawson (now global law firm Ashurst) from 1990 to 2014. She specialised in corporate and commercial law and, in particular, cross-border mergers and acquisitions and corporate governance. She was a member of the Australian Takeovers Panel (2001-2010) and Chair of the Corporations Committee of the Business Law Section of the Law Council of Australia (2012, 2013) and a deputy chair (2010, 2011). Prior to becoming a lawyer, Ms McDonald completed a Bachelor of Science (Honours) degree with first class honours, majoring in chemistry. Ms McDonald is a non-executive director of CSL Limited, Nanosonics Limited and Nufarm Limited. |
|
Dr Graham Mitchell AO
RDA BVSc Sydney FACVSc PhD Melbourne FTSE FAA Dr Mitchell completed his PhD at the Walter and Eliza Hall Institute in the late 1960s that involved the discovery of T and B cells. In 1973 after postdoctoral experience in the United States, United Kingdom and Switzerland, Dr Mitchell returned to the Institute and established the Parasitology/Malaria program. He was also a previous director of research in the R&D Division of CSL Limited. Dr Mitchell is an adviser on science and innovation to the Victorian Government and is a Principal of Foursight Associates. He is a non-executive director of Antisense Therapeutics Limited and Avipep Pty Ltd and has a detailed knowledge of the academia-industry interface and global health. |
|
Professor Sir John Savill
BA Oxford MBChB Sheffield PhD London FRCP FRCPE FRCSEd(Hon) FRCPCH(Hon) FASN FRSE F.MedSci FRS Professor Sir John Savill is a physician scientist who has been based at the University of Edinburgh since 1998. His clinical interests have been in nephrology and general internal medicine, with research focussing on clearance of dying cells as a key control point in inflammatory responses. In 2000 he established the MRC Centre for Inflammation Research in Edinburgh as inaugural Director. Between 2002 and 2012 he served as Vice-Principal and Head of the College of Medicine and Veterinary Medicine at the University of Edinburgh. This role was combined with spells as Chief Scientist in the Scottish Government Health Directorates (2008-10) and Chief Executive of the UK Medical Research Council (2010-18), having previously served as a member of MRC Council and Research Board Chair (2002-8). In 2017 Her Majesty The Queen appointed him to the Regius Chair of Medical Science at the University of Edinburgh, where he now directs the Wellcome Trust Edinburgh Clinical Academic Track. His contributions to medical research, innovation and practice have been recognised by various fellowships, most notably those from the Royal Society and Academy of Medical Sciences, and he was knighted in 2008 for services to clinical science. |
|
Mr Terry Moran AC
BA (Hons) LaTrobe Mr Terry Moran is the former secretary of the Department of Prime Minister and Cabinet and former secretary of the Victorian Department of Mr Moran’s involvement in the public service has resulted in the establishment of institutions that have made important contributions to Australia’s cultural and educational landscape, such as the Wheeler Centre, the Grattan Institute, Opera Victoria, the Melbourne Recital Centre, the Australian and New Zealand School of Government and the National Institute of Public Policy. He is the board chair for both the Barangaroo Delivery Authority and Melbourne Theatre Company, chair of the Centre for Policy Development, and holds the position of senior advisor at the Boston Consulting Group. |
|
Ms Carolyn Viney
LLB/BA Monash Ms Carolyn Viney has more than 20 years’ experience in construction, property development and real estate investment. Ms Viney is currently Executive General Manager Development at Vicinity Centres. Over a 13-year period she held a number of senior roles at Grocon, including CEO, deputy CEO, head of development and in-house counsel. Before this, she was a senior associate at law firm Minter Ellison. Ms Viney is a division councillor of the Property Council of Australia’s Victoria Division, an advisory board member to the Victorian Government’s Office of Projects Victoria and an Advisory Board Member of Women’s Property Initiatives, a not-for-profit housing provider to women and children at risk of homelessness. |